Anti-tubercular agents. Part 7: A new class of diarylpyrrole-oxazolidinone conjugates as antimycobacterial agents

European Journal of Medicinal Chemistry

Volumn 64, Issue , 2013, Pages 239-251

  Kamal, Ahmed ^a   Swapna, P ^a   Shetti, Rajesh V C R N C ^a   Shaik, Anver Basha ^a   Narasimha Rao, M P ^a   Sultana, Farheen ^a   Khan, Inshad Ali ^b   Sharma, Sandeep ^b   Kalia, Nitin Pal ^b   Kumar, Sunil ^b   Chandrakant, Bagul ^c  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^c NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Anti tubercular agents; Antibacterial; MDR and XDR TB; Mycobacterium tuberculosis; Oxazolidinones

Indexed keywords

1 (2 BROMO 5 FLUOROPHENYL) 2 (2,4 DIFLUOROPHENYL) 5 METHYL 1H PYRROLE; 1 (3,4 DICHLOROPHENYL) 2 METHYL 5 4 TOLYL 1H PYRROLE; 1 (3,4 DIFLUOROPHENYL) 2 (4 ISOPROPYLPHENYL) 5 METHYL 1H PYRROLE; 1 (4 FLUOROPHENYL) 2 METHYL 5 2 TOLYL 1H PYRROLE; 1 (4 TRIFLUOROMETHOXYPHENYL) 2 METHYL 5 (4 CHLORO 3 FLUOROLPHENYL)PYRROLE; 2 (2,4 DIFLUOROPHENYL) 1 (4 FLUOROPHENYL) 5 METHYLPYRROLE; 2 (3 CHLOROPHENYL) 1 (2 FLUOROPHENYL) 5 METHYLPYRROLE; ANTIMYCOBACTERIAL AGENT; DIARYLPYRROLE OXAZOLIDINONE CONJUGATE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG DETERMINATION; DRUG DEVELOPMENT; DRUG POTENCY; DRUG RESISTANCE; DRUG SYNTHESIS; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; PANEL STUDY;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GRAM-POSITIVE BACTERIA; MICE; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; OXAZOLIDINONES; PYRROLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84877083796     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2013.03.027     Document Type: Article

References (34)

1. World Health Organization 47th World Health Assembly: Provisional Agenda Item 19, Tuberculosis-Progress Report by the Director General, Document WHA47/1994/A47/12, Geneva, Switzerland 1994
2. World Health Organization Global Tuberculosis Control: WHO Report 2011 Further info at the web site: http://www.who.int/gtb/
3. World Health Organization Global Tuberculosis Control: Surveillance, Planning, Financing, WHO Report 2004, Geneva, Switzerland 2004
4. J.P. Cegielski, D.P. Chin, M.A. Espinal, T.R. Frieden, R. Rodriquez Cruz, E.A. Talbot, D.E. Weil, R. Zaleskis, and M.C. Raviglione The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century Infect. Dis. Clin. North Am. 161 2002 1 58 (Pubitemid 34240051)
5. T.R. Frieden, and S.S. Munsiff The DOTS strategy for controlling the global tuberculosis epidemic Clin. Chest Med. 26 2005 197 205
6. J.D. Mckinney, W.R.J. Jacobs, B.R. Bloom, and R.M. Krause 1998 Academic Press New York 51 146
7. H. Tomioka Curr. Pharm. Des. 12 2006 4047 4070
8. D. Maher, and M. Raviglione Clin. Chest Med. 26 2005 168 182
9. L.G. Dover, and G.D. Coxon J. Med. Chem. 54 2011 6157 6165
10. N. Pandit, R.K. Singla, and B. Shrivastava Int. J. Med. Chem. 2011 1 24 (Article ID 159285)
11. M.R. Sarbachyn, and C.W. Ford Angew. Chem. Int. Ed. 42 2003 2010 2030
12. J.C. Rodriguez, M. Ruiz, M. Lopez, and G. Royo Int. J. Antimicrob. Agents 20 2002 464 467
13. S.J. Brickner, M.R. Barbachyn, D.K. Hutchinson, and P.R. Manninen J. Med. Chem. 51 2008 1981 1990
14. J.A. Ippolito, Z.F. Kanyo, D. Wang, F.J. Franceschi, P.B. Moore, T.A. Steitz, and E.M. Duffy J. Med. Chem. 51 2008 3353 3356
15. O.A. Phillips, E.E. Udo, A.A.M. Ali, and N. Al-Hassawi Bioorg. Med. Chem. 11 2003 35 41
16. O.A. Phillips, E.E. Udo, A.A.M. Ali, and S.M. Samuel Bioorg. Med. Chem. 13 2005 4113 4123
17. F. Reck, F. Zhou, M. Girardot, G. Kern, C.J. Eyermann, N.J. Hales, R.R. Ramsay, and M.B. Gravestock J. Med. Chem. 48 2005 499 506
18. T. Komine, A. Kojima, Y. Asahina, T. Saito, H. Takano, T. Shibue, and Y. Fukuda J. Med. Chem. 51 2008 6558 6562
19. D. Deidda, G. Lampis, R. Fioravanti, M. Biava, G.C. Porretta, S. Zanetti, and R. Pompei Antimicrob. Agents Chemother. 42 1998 3035 3037
20. M. Biava, G.C. Porretta, G. Poce, S. Supino, D. Deidda, R. Pompei, P. Molicotti, F. Manetti, and M. Botta J. Med. Chem. 49 2006 4946 4952
21. A. Kamal, R.V.C.R.N.C. Shetti, S. Azeeza, S.K. Ahmed, P. Swapna, A.M. Reddy, I.A. Kahn, S. Sharma, and S.T. Abdullah Eur. J. Med. Chem. 45 2010 4545 4553
22. A. Kamal, R.V.C.R.N.C. Shetti, S. Azeeza, P. Swapna, M.N.A. Khan, A.M. Reddy, I.A. Kahn, S. Sharma, and S.T. Abdullah Eur. J. Med. Chem. 46 2011 893 900
23. A. Kamal, K.S. Reddy, S.K. Ahmed, M.N.A. Khan, R.K. Sinha, J.S. Jadav, and S.K. Arora Bioorg. Med. Chem. 14 2006 650 658
24. S.J. Brickner, D.K. Hutchinson, M.R. Barbachyn, P.R. Manninen, D.A. Ulanowicz, S.A. Garmon, K.C. Grega, S.K. Hendges, D.S. Toops, C.W. Ford, and G.E. Zurenko J. Med. Chem. 39 1996 673 679
25. M.R. Barbachyn, D.K. Hutchinson, S.J. Brickner, M.H. Cynamon, J.O. Kilburn, S.P. Klemens, S.E. Glickman, K.C. Grega, S.K. Hendges, D.S. Toops, C.W. Ford, and G.E. Zurenko J. Med. Chem. 39 1996 680 685
26. H.C. Kolb, M.G. Finn, and K.B. Sharpless Angew. Chem. Int. Ed. 40 2001 2004 2021
27. F. Pagliai, T. Pirali, E.D. Grosso, R.D. Brisco, G.C. Tron, G. Sorba, and A.A. Genazzani J. Med. Chem. 49 2006 467 470
28. R. Maccari, R. Ottana, F. Monforte, and M.G. Vigorita Antimicrob. Agents Chemother. 46 2002 294 299
29. R.J. Wallace, D.R. Nash, L.C. Steele, and V. Steingrube J. Clin. Microbiol. 24 1986 976 981
30. I. Orme, J. Secrist, S. Anathan, C. Kwong, J. Maddry, R. Reynolds, A. Poffenberger, M. Michael, L. Miller, J. Krahenbuh, L. Adams, A. Biswas, S. Franzblau, D. Rouse, D. Winfield, and J. Brooks Antimicrob. Agents Chemother. 45 2001 1943 1946
31. National Committee for Clinical Laboratory Standards Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically Approved Standard, NCCLS Document M7-A4 fourth ed. 1997 National Committee for Clinical Laboratory Standards Villanova, PA
32. M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G.A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H.P. Hratchian, A.F. Izmaylov, J. Bloino, G. Zheng, J.L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J.J.A. Montgomery, J.E. Peralta, F. Ogliaro, M. Bearpark, J.J. Heyd, E. Brothers, K.N. Kudin, V.N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J.C. Burant, S.S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J.M. Millam, M. Klene, J.E. Knox, J.B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R.E. Stratmann, O. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W. Ochterski, R.L. Martin, K. Morokuma, V.G. Zakrzewski, G.A. Voth, P. Salvador, J.J. Dannenberg, S. Dapprich, A.D. Daniels, Ö. Farkas, J.B. Foresman, J.V. Ortiz, J. Cioslowski, and D.J. Fox Gaussian 09, Revision B.1 2010 Gaussian, Inc. Wallingford, CT
33. Maestro, Version 9.3 2012 Schrödinger, LLC New York, NY
34. The PyMOL Molecular Graphics System, Version 1.5.0.4, Schrödinger, LLC, 2012.